In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
about
Focal Targeting of the Bacterial Envelope by Antimicrobial PeptidesMechanisms of drug resistance: daptomycin resistanceCyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteriaEmergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting.Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin ActivityAntimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.Site-specific mutation of the sensor kinase GraS in Staphylococcus aureus alters the adaptive response to distinct cationic antimicrobial peptides.Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.Role of the Vibrio cholerae matrix protein Bap1 in cross-resistance to antimicrobial peptides.Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operonsStaphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.Comparison of antibacterial effects between antimicrobial peptide and bacteriocins isolated from Lactobacillus plantarum on three common pathogenic bacteriaFrequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial PeptidesTXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.Differential Adaptations of Methicillin-Resistant Staphylococcus aureus to Serial In Vitro Passage in Daptomycin: Evolution of Daptomycin Resistance and Role of Membrane Carotenoid Content and Fluidity.Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients.Fatty acids regulate stress resistance and virulence factor production for Listeria monocytogenes.Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin SynergyWhole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapyCorrelation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Bacterial Evasion of Host Antimicrobial Peptide DefensesThe RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant.A current perspective on daptomycin for the clinical microbiologist.Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides.Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureusBacterial resistance to cationic antimicrobial peptides.Peptide antimicrobials: cell wall as a bacterial target.Emerging drugs on methicillin-resistant Staphylococcus aureus.Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy.Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and EnterococciPhenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.The role of two branched-chain amino acid transporters in Staphylococcus aureus growth, membrane fatty acid composition and virulence.
P2860
Q26744785-5AA416B9-7391-4EF6-ADDB-3AA6A4F26933Q26779944-842F6B18-5115-4A9C-9943-E49C997F965CQ26863225-B0669C0A-5FC7-4D65-9C8B-313B236DD522Q31131146-7CF6FC37-C86B-48D9-B1D2-63001EBC9273Q33703659-59BDE3AF-51C6-4EFB-97F7-712779A88C5FQ33939055-1BFA9E87-697B-48A8-BAA2-73F1E3BB2CC2Q34549813-2F83B02F-AE37-4AD6-B09D-9C041BB8821DQ34595733-2A4178CB-D0C6-4306-8DB3-E289CC510300Q34597770-FAC11369-2035-433F-A567-FE16CD34B7F8Q34648042-562C3883-B402-426D-B8DE-72F59FD5F86AQ34779009-FC30122B-B96B-4D4E-9A43-61AB9DD84122Q35008777-23C0CCB8-CD07-4695-9E86-5AB987491226Q35256159-0348C52C-3F58-4087-BF08-B67D4B3AD17AQ35746096-88D2E568-383F-47DD-9788-FA7CFA5E62D2Q35791791-30E2175D-AF85-473F-A1C7-A04AA60B7368Q35860154-7E287884-15CE-47BF-854D-2A41C8779D52Q35860159-A19B3EC9-88D5-4FC9-8D7A-398E524CBEA3Q36200018-D11B2ED6-BE04-4156-AE64-08A3FB011CC6Q36253014-5FBDF7A2-EF43-4A92-8B49-923188C12C43Q36276434-0DDC5139-38FF-4A9E-B1FE-17611AAE8165Q36439093-8305E259-6581-439A-9711-54ACBF1A5E1AQ36505376-5EF5F226-FA87-4B00-9A6A-6FE24374ECC1Q36558432-8313BA82-42AE-4147-A631-CBC437817C10Q36565462-032D9775-7115-445A-9494-9CE44EF3D3BBQ36667211-9E832522-15C0-4B61-9E31-D4EA976DD891Q36720179-8513355C-0785-408C-9A2E-B72DD5572CA3Q36787486-5F8F758B-5D7E-4C53-9602-A505CE65384BQ37190222-45887782-4199-47AD-A17B-452D1DCCC649Q37263289-49425935-BEAD-4FD6-B754-328B531EDF64Q37509520-4CA0FBEB-C17F-415B-BF06-1D75D5764F78Q37588890-6D543DD6-8D35-4983-AE77-6DCCD5B95A91Q38026594-A742193E-E22F-4EE4-A550-13F814742631Q38072770-EA5C0B5A-095F-44F8-A7B9-08767D59B073Q38121142-1DB264A7-C7C1-4F3B-AEEB-F9DA8436EA47Q38232494-D04CAD48-F519-4B7D-B3E4-61AA84D62DFCQ38462842-12885054-43C8-4052-96A8-D96DD7516E92Q38895642-4E8F126A-FB2B-4626-B952-670BB3D4C8A4Q38942573-E40A7697-AEEC-4D31-B15E-D1794820B10CQ39000860-7BBB086E-E74A-4DDC-B079-12F473F2CBB7Q39428221-11CB02D1-D186-4078-B3CE-B8C10A7AA328
P2860
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In vitro cross-resistance to d ...... taphylococcus aureus isolates.
@ast
In vitro cross-resistance to d ...... taphylococcus aureus isolates.
@en
type
label
In vitro cross-resistance to d ...... taphylococcus aureus isolates.
@ast
In vitro cross-resistance to d ...... taphylococcus aureus isolates.
@en
prefLabel
In vitro cross-resistance to d ...... taphylococcus aureus isolates.
@ast
In vitro cross-resistance to d ...... taphylococcus aureus isolates.
@en
P2093
P2860
P356
P1476
In vitro cross-resistance to d ...... taphylococcus aureus isolates.
@en
P2093
Aileen Rubio
Arnold S Bayer
Barry N Kreiswirth
Cynthia C Nast
James McKinnell
Liang Chen
Michael R Yeaman
Nagendra N Mishra
P2860
P304
P356
10.1128/AAC.00223-11
P407
P577
2011-06-27T00:00:00Z